Journal of dentistry · 2026
A bioactive radiopaque infiltrant for managing early enamel carious lesions - an in-vitro study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hasan Mahmoud Abdelgawad, Khatoon Amina, Arseniyadis Stellios, Patel Mangala, Hill Robert, Wong Ferranti S L
Аннотация
OBJECTIVES: To develop a bioactive radiopaque infiltrant (BRI), compare its radiopacity and degree of conversion (DC%) to ICON, and evaluate its ion release, infiltration into artificial caries, and acid-resistant bioactivity.
METHODS: BRI was prepared with 30% non-silanated fluoride-containing bioactive glass (FBG) and 70% radiopaque resin infiltrant (RI) comprising 2,2,2-tribromoethyl methacrylate, TEGDMA, and UDMA. Degree of conversion and radiopacity were measured via FTIR and digital radiography, with ICON as control. Artificial enamel lesions (n = 10) were infiltrated with BRI (without HCl pre-conditioning) and divided into pH 4 and pH 7 immersion groups (n = 5 each). Bioactivity was assessed by ISE, ICP-OES, XRD, and SEM. Penetration depth and mineral changes were tracked using X-ray microtomography (XMT) at baseline, 8 weeks, and 23 weeks.
RESULTS: BRI showed significantly higher DC (84.9%) than ICON (74%) and radiopacity of 3.2 mm Al equivalent (vs. 2.0 mm for enamel). Sustained Ca²⁺ and F⁻ release over 23 weeks was greater at pH 4 than pH 7. XRD and SEM confirmed hydroxyapatite formation on infiltrated surfaces, while XMT revealed radiopacity increases consistent with progressive mineral deposition.
CONCLUSION: A 30% FBG loading maintained both resin penetrability and sustained bioactivity.
CLINICAL SIGNIFICANCE: This novel BRI enables radiographic monitoring of proximal early caries while providing acid-buffering protection, offering a potential advance over conventional non-bioactive infiltrants.
METHODS: BRI was prepared with 30% non-silanated fluoride-containing bioactive glass (FBG) and 70% radiopaque resin infiltrant (RI) comprising 2,2,2-tribromoethyl methacrylate, TEGDMA, and UDMA. Degree of conversion and radiopacity were measured via FTIR and digital radiography, with ICON as control. Artificial enamel lesions (n = 10) were infiltrated with BRI (without HCl pre-conditioning) and divided into pH 4 and pH 7 immersion groups (n = 5 each). Bioactivity was assessed by ISE, ICP-OES, XRD, and SEM. Penetration depth and mineral changes were tracked using X-ray microtomography (XMT) at baseline, 8 weeks, and 23 weeks.
RESULTS: BRI showed significantly higher DC (84.9%) than ICON (74%) and radiopacity of 3.2 mm Al equivalent (vs. 2.0 mm for enamel). Sustained Ca²⁺ and F⁻ release over 23 weeks was greater at pH 4 than pH 7. XRD and SEM confirmed hydroxyapatite formation on infiltrated surfaces, while XMT revealed radiopacity increases consistent with progressive mineral deposition.
CONCLUSION: A 30% FBG loading maintained both resin penetrability and sustained bioactivity.
CLINICAL SIGNIFICANCE: This novel BRI enables radiographic monitoring of proximal early caries while providing acid-buffering protection, offering a potential advance over conventional non-bioactive infiltrants.